Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Are drug provocation tests still necessary to test the safety of COX-2 inhibitors in patients with cross-reactive NSAID hypersensitivity?

Çelik GE, Erkekol FÖ, Aydın Ö, Demirel YS, Mısırlıgil Z.

Allergol Immunopathol (Madr). 2013 May-Jun;41(3):181-8. doi: 10.1016/j.aller.2012.03.006. Epub 2012 Sep 30.

PMID:
23031659
2.

Tolerability of three selective cyclo-oxygenase-2 inhibitors, meloxicam, celecoxib and rofecoxib in NSAID-sensitive patients.

Senna G, Bilò MB, Antonicelli L, Schiappoli M, Crivellaro MA, Bonadonna P, Dama AR.

Eur Ann Allergy Clin Immunol. 2004 Jun;36(6):215-8.

PMID:
15329003
4.
5.

Response to a selective COX-2 inhibitor in patients with urticaria/angioedema induced by nonsteroidal anti-inflammatory drugs.

Doña I, Blanca-López N, Jagemann LR, Torres MJ, Rondón C, Campo P, Gómez AI, Fernández J, Laguna JJ, Rosado A, Blanca M, Canto G.

Allergy. 2011 Nov;66(11):1428-33. doi: 10.1111/j.1398-9995.2011.02684.x. Epub 2011 Aug 11.

6.

Safety of meloxicam in patients with aspirin/non-steroidal anti-inflammatory drug-induced urticaria and angioedema.

Göksel O, Aydin O, Misirligil Z, Demirel YS, Bavbek S.

J Dermatol. 2010 Nov;37(11):973-9. doi: 10.1111/j.1346-8138.2010.00948.x. Epub 2010 Aug 16.

PMID:
21039786
7.

The safety of codeine in patients with non-steroidal anti-inflammatory drug hypersensitivity: a preliminary study.

Celebioglu E, Karakaya G, Kalyoncu AF.

Allergol Immunopathol (Madr). 2013 May-Jun;41(3):163-8. doi: 10.1016/j.aller.2012.04.010. Epub 2012 Sep 30.

PMID:
23031656
8.

Tolerance of nonsteroidal anti-inflammatory drug-sensitive patients to the highly specific cyclooxygenase 2 inhibitors rofecoxib and valdecoxib.

Sánchez-Borges M, Caballero-Fonseca F, Capriles-Hulett A.

Ann Allergy Asthma Immunol. 2005 Jan;94(1):34-8.

PMID:
15702813
9.

Tolerance to COX-2 inhibitors in children with hypersensitivity to nonsteroidal anti-inflammatory drugs.

Corzo JL, Zambonino MA, Muñoz C, Mayorga C, Requena G, Urda A, Gallego C, Blanca M, Torres MJ.

Br J Dermatol. 2014 Mar;170(3):725-9. doi: 10.1111/bjd.12674.

PMID:
24116718
10.

Safety of etoricoxib, a new cyclooxygenase 2 inhibitor, in patients with nonsteroidal anti-inflammatory drug-induced urticaria and angioedema.

Sánchez-Borges M, Caballero-Fonseca F, Capriles-Hulett A.

Ann Allergy Asthma Immunol. 2005 Aug;95(2):154-8.

PMID:
16136765
11.

Determining safe alternatives for multidrug hypersensitive patients with the alternative triple antibiotic-analgesic test.

Ozturk AB, Celebioglu E, Karakaya G, Kalyoncu AF.

Allergol Immunopathol (Madr). 2013 May-Jun;41(3):189-93. doi: 10.1016/j.aller.2012.01.007. Epub 2012 May 3.

PMID:
22559997
12.
13.

Safety of the new selective cyclooxygenase type 2 inhibitors rofecoxib and celecoxib in patients with anaphylactoid reactions to nonsteroidal anti-inflammatory drugs.

Quiralte J, Delgado J, Sáenz de San Pedro B, López-Pascual E, Nieto MA, Ortega N, Florido JF, Conde J.

Ann Allergy Asthma Immunol. 2004 Oct;93(4):360-4.

PMID:
15521372
15.

Early presentation with angioedema and urticaria in cross-reactive hypersensitivity to nonsteroidal antiinflammatory drugs among young, Asian, atopic children.

Kidon MI, Kang LW, Chin CW, Hoon LS, See Y, Goh A, Lin JT, Chay OM.

Pediatrics. 2005 Nov;116(5):e675-80. Epub 2005 Oct 17.

PMID:
16230465
16.

Safety of celecoxib in patients with adverse skin reactions to acetaminophen (paracetamol) and nimesulide associated or not with common non-steroidal anti-inflammatory drugs.

Liccardi G, Salzillo A, Piccolo A, Senna G, Piscitelli E, D'Amato M, D'Amato G.

Eur Ann Allergy Clin Immunol. 2005 Feb;37(2):50-3.

PMID:
15859361
17.

Meloxicam tolerance in hypersensitivity to nonsteroidal anti-inflammatory drugs.

Domingo MV, Marchuet MJ, Culla MT, Joanpere RS, Guadaño EM.

J Investig Allergol Clin Immunol. 2006;16(6):364-6.

18.

Tolerability of selective cyclooxygenase inhibitor, celecoxib, in patients with analgesic intolerance.

Celik G, Paşaoğlu G, Bavbek S, Abadoğlu O, Dursun B, Mungan D, Misirligil Z.

J Asthma. 2005 Mar;42(2):127-31.

PMID:
15871445
19.

Drug provocation tests in the diagnosis of hypersensitivity reactions to non-steroidal anti-inflammatory drugs in children.

Zambonino MA, Torres MJ, Muñoz C, Requena G, Mayorga C, Posadas T, Urda A, Blanca M, Corzo JL.

Pediatr Allergy Immunol. 2013 Mar;24(2):151-9. doi: 10.1111/pai.12039.

PMID:
23506290
20.

Supplemental Content

Support Center